# Effectiveness of Pulmozyme in Infants With Cystic Fibrosis

> **NCT00179998** · PHASE2 · COMPLETED · sponsor: **Nationwide Children's Hospital** · enrollment: 24 (actual)

## Conditions studied

- Cystic Fibrosis

## Interventions

- **DRUG:** Recombinant Human DNase (Pulmozyme)
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT00179998
- **Lead sponsor:** Nationwide Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2008-10
- **Final completion:** 2016-07
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2019-05-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00179998

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00179998, "Effectiveness of Pulmozyme in Infants With Cystic Fibrosis". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT00179998. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*